Clinical Trial Update: Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy of PMZ-2010 (Centhaquine) as a resuscitative agent for hypovolemic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolemia Shock

Drugs mentioned

• PMZ-2010 (Centhaquine) (Centhaquine)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Hypovolemic Shock | Phase 3 | Status: COMPLETED